Cytokinetics Inc insider trades

as of filings through Nov 3, 2026

Hide plannedHide planned trades

FiledStockInsiderSideValueSharesAvg priceTraded

Filed Nov 3, 4:38 PM (the Form 4 at the SEC), traded Nov 3CYTKSoldFady Ibraham Malik · EVP Research & DevelopmentPlanSell$220K3,500$62.93Nov 3
Filed Nov 2, 6:18 PM (the Form 4 at the SEC), traded Nov 2CYTKSoldRobert I. Blum · President & CEO, DirectorPlanSell$471K7,500$62.81Nov 2
Filed Oct 20, 4:21 PM (the Form 4 at the SEC), traded Oct 20CYTKSoldFady Ibraham Malik · EVP Research & DevelopmentPlanSell$224K3,500$64.01Oct 20
Filed Oct 13, 4:00 PM (the Form 4 at the SEC), traded Oct 12CYTKSoldRobert I. Blum · President & CEO, DirectorPlanSell$472K7,500$62.88Oct 12
Filed Oct 6, 4:25 PM (the Form 4 at the SEC), traded Oct 6CYTKSoldFady Ibraham Malik · EVP Research & DevelopmentPlanSell$215K3,500$61.38Oct 6
Filed Sep 28, 4:54 PM (the Form 4 at the SEC), traded Sep 28CYTKSoldRobert I. Blum · President & CEO, DirectorPlanSell$491K7,500$65.46Sep 28
Filed Sep 22, 6:14 PM (the Form 4 at the SEC), traded Sep 22CYTKSoldFady Ibraham Malik · EVP Research & DevelopmentPlanSell$239K3,500$68.29Sep 22
Filed Sep 15, 5:23 PM (the Form 4 at the SEC), traded Sep 15CYTKSoldRobert E. Landry · DirectorPlanSell$72.1K1,000$72.13Sep 15
Filed Sep 15, 5:20 PM (the Form 4 at the SEC), traded Sep 15CYTKSoldRobert I. Blum · President & CEO, DirectorPlanSell$7.3M105K$69.62Sep 15
Filed Sep 11, 7:12 PM (the Form 4 at the SEC), traded Sep 11CYTKSoldRobert E. Landry · DirectorPlanSell$74.7K1,000$74.66Sep 11

CYTK against its rivals

No comparison pages for CYTK.